Aidoc Receives FDA Breakthrough Device Designation for AI That Drafts Radiology Reports

▤ Summary

Aidoc received FDA Breakthrough Device Designation for First Read, an AI tool that drafts preliminary radiology report text from chest radiographs. The company says the product is meant to reduce reporting bottlenecks and help radiologists handle rising imaging volumes more efficiently. First Read extends Aidoc’s clinical AI platform and builds on the same foundation used in its existing FDA-cleared triage application. The announcement also highlights Aidoc’s broader enterprise deployment across nearly 2,000 hospitals and its recent $150 million Series E financing.

▦ Linked Companies

Aidoc

$1M to $5M